POET Forward Catalyst Calendar
This file enumerates the discrete forward events that will materially update the POET thesis between 2026-04-29 and the end-2027 horizon. Each catalyst is mapped to (a) its date or expected window, (b) its primary thesis significance (which bull / bear pillar or risk it tests), and (c) the disclosure path that would surface the result. Used together with the risks register, this catalyst calendar is the analytical scaffolding for monitoring the position thesis quarter-by-quarter.
POET’s foreign-private-issuer status means the disclosure cadence is structurally lighter than US-domestic-issuer peers: 20-F annual + 6-K interim, with no quarterly 10-Q + 8-K + Form 4 stream. The catalyst calendar therefore emphasizes 6-K filing windows + IR press-release events + industry-conference disclosure windows.
Near-term (next 6 months: May 2026 - October 2026)
| Date / window | Event | Thesis significance | Disclosure path |
|---|---|---|---|
| Mid-May 2026 (target) | Q1 2026 6-K interim release | First post-FY25-20-F operating data point. Will disclose Q1 2026 NRE + product revenue, customer-engagement progress, cash position, R&D + opex run-rate. Tests bull case Pillar 5 production-cadence math + risks C1 + K1. | SEC EDGAR 6-K filing + GlobeNewswire press release + POET IR letter to shareholders. |
| June 2026 (typical AGM window) | POET Annual General Meeting (AGM) 2026 | Management presentation typically covers full-year strategic priorities, IP portfolio updates, partner-relationship status. AGM 2026 may include US-redomicile vote / status update. | AGM proxy materials (SEDAR + SEC), live management Q&A, IR slide deck. |
| August 2026 (target) | Q2 2026 6-K interim release | Mid-year operating data point. First half-year tracking against the 30,000+ engine 2026 commitment. | SEC EDGAR 6-K. |
| September 2026 | CIOE 2026 (Shenzhen, target Sept 2026) | China Optoelectronics Exposition. Historical POET disclosure venue for new product reveals (1.6T receiver disclosed at CIOE 2025 GlobeNewswire 2025-09-04 ✓). 2026 reveals could include first 3.2T product demos (QCi collaboration) or new module-OEM-design-win disclosures. | POET IR press release + CIOE program materials. |
| September 2026 | ECOC 2026 (Brussels, target Sept 21-25 2026) | European Conference on Optical Communication. Historical POET disclosure venue (ECOC 2025 “Most Innovative” award GlobeNewswire 2025-09-30 ✓). Tests risks T5 (CPO architectural shift) — ECOC 2026 disclosures will reveal whether merchant-pluggable layer is holding share vs. CPO encroachment. | POET IR + conference presentation slide decks + Semiconductor Today / Semiconductor Digest coverage. |
| October-December 2026 | First production shipments under the disclosed $5M order (POET IR 2025-10-22 ✓) | Production shipments scheduled for “second half of 2026” — first revenue recognition window. Tests bull case Pillar 5 + risks T1 (yield), F1 (SilTerra capacity), C1 (single-customer concentration). | Q3 2026 6-K (target November 2026); module-OEM customer announcement (if any); revenue concentration disclosure in FY26 20-F. |
Mid-term (6-18 months: November 2026 - October 2027)
| Date / window | Event | Thesis significance | Disclosure path |
|---|---|---|---|
| November 2026 (target) | Q3 2026 6-K interim release | Q3 2026 revenue trajectory. First full quarter of production shipments expected. Verifies the 30,000+ engine 2026 trajectory. | SEC EDGAR 6-K. |
| March 2027 (target) | Q4 2026 6-K + FY26 financial release | Full-year 2026 revenue total. Critical bull case Pillar 5 verification: did the production-volume math hold? | GlobeNewswire press release + 6-K filing. |
| March 2027 (target) | OFC 2027 (San Diego, March 2027) | Optical Fiber Communication conference — premier industry venue. Hyperscaler module-spec disclosures, 3.2T architecture disclosures, CPO-vs-pluggable architectural inflection visibility. Tests risks T5, X1. POET historical OFC presence + product reveals. | POET IR + conference program. |
| March-April 2027 (target) | FY26 20-F filing | Full audited financial statements + customer-concentration disclosures + risk-factor diff (per data/risk_factor_diff.json tracking). PFIC determination + US-redomicile track update. Material risks update + auditor opinion. | SEC EDGAR 20-F. |
| April-May 2027 (target) | Q1 2027 6-K interim release | Tests whether 2H 2026 production momentum carried into 2027. Tests bear case Pillar 2 (“nearly there since [year]”) falsification: if Q1 2027 product revenue prints meaningfully above the 2026 run-rate, the eight-year execution-risk pattern is broken. | SEC EDGAR 6-K. |
| June 2027 (typical AGM window) | POET AGM 2027 | Two-year strategic-priority update. US-redomicile vote outcome (if not completed at AGM 2026). | AGM proxy materials. |
| August 2027 (target) | Q2 2027 6-K interim release | First half 2027 revenue total. Probability assessment of additional capital raise need (risks K1) — at $170M annualized burn, second-half-2027 cash position becomes a forward concern if no commercial-revenue inflection has happened. | SEC EDGAR 6-K. |
| September 2027 (target) | ECOC 2027 (target Sept 2027) | Third consecutive ECOC POET track. Tests architectural-positioning competitive narrative two years out. | POET IR + conference materials. |
Long-term (18+ months: November 2027 - end-2029)
| Date / window | Event | Thesis significance | Disclosure path |
|---|---|---|---|
| March 2028 (target) | OFC 2028 + FY27 20-F filing | Critical inflection check: 1.6T product cycle should be in volume by this window (Sivers DFB lasers in production end-2026, NTT high-volume production targeted 2027 POET IR ✓). FY27 20-F audit opinion + risk-factor disclosure. | SEC EDGAR 20-F + OFC program. |
| 2028-2029 | 3.2T product-cycle commercialization (QCi TFLN collaboration) | Long-term product cycle. Tests risks X4 (TFLN modulator-IP competition). | POET IR + module-OEM design-win announcements. |
| 2028-2029 | Possible US-redomicile completion | Resolves risks K4 (PFIC). Opens broader US institutional investor base. | SEC EDGAR 20-F change of control / 10-K / NT-10 sequence; SEDAR Canadian deregistration. |
| 2027-2028 | Hyperscaler customer naming (if any) | The single highest-value catalyst for re-rating: any named hyperscaler-tier customer (AWS, Microsoft, Google, Meta) — directly or through a named module-OEM design win — tests bear case Pillar 3 (NDA-shielded customer base) falsification. | POET IR press release + module-OEM partner press release; 20-F revenue-concentration disclosure. |
| 2028-2030 | Industry-wide CPO architecture inflection | Tests risks T5 + X3. If CPO-dominant architecture displaces merchant pluggables at hyperscaler scale by 2028-2030, POET’s product roadmap must re-pivot around the Sivers-collaboration ELS opportunity. | OFC, ECOC, OCP, SC industry-conference disclosures. |
Risk-mapping summary table
Cross-references each catalyst to the most-tested risk IDs in risks:
| Catalyst window | Tests bull pillars | Tests bear pillars | Tests risk IDs |
|---|---|---|---|
| Q1 2026 6-K (May 2026) | Pillar 5 | Pillar 1, Pillar 2 | C1, K1, T1 |
| AGM 2026 (June 2026) | Pillar 3 | Pillar 4 | K3, K4 |
| Q2 2026 6-K (August 2026) | Pillar 5 | Pillar 2 | C1, T1 |
| CIOE 2026 / ECOC 2026 (Sept 2026) | Pillar 1, Pillar 4 | Pillar 5 | T5, X1, X3 |
| First production shipments (Q3-Q4 2026) | Pillar 1, Pillar 5 | Pillar 1, Pillar 2 | T1, T2, F1, C1 |
| Q3-Q4 2026 6-Ks (Nov 2026, Mar 2027) | Pillar 5 | Pillar 1, Pillar 2 | C1, C2, C3, K1 |
| FY26 20-F (March-April 2027) | Pillar 5 | Pillar 1, Pillar 5 | K3, K4, IP1, IP5 |
| OFC 2027 (March 2027) | Pillar 1, Pillar 4 | Pillar 5 | T5, X1, X3, X4 |
| 1.6T product cycle (2026-2027) | Pillar 1, Pillar 4 | Pillar 5 | T3, T4, X1 |
| 3.2T product cycle (2027-2028) | Pillar 4 | Pillar 5 | T3, X4 |
| Hyperscaler customer naming (2027-2028) | Pillar 3, Pillar 5 | Pillar 3 | C2, C3 |
| US-redomicile (2028-2029) | (capital structure) | Pillar 1 | K4, IP5 |
Aggregate-thesis re-rating windows
The catalyst calendar identifies three discrete windows when the POET thesis can mechanically re-rate to the bull / base / bear case end-points described in bull case Pillar 5 and bear case Pillar 1:
- Q3-Q4 2026 (production-shipment confirmation): the first quarter where revenue tracks materially above the implied $2.5M-$3.75M / quarter run-rate would confirm the 30,000+ engine commitment and re-rate toward bull-case math. A miss confirms the bear-case execution-risk pattern.
- March-April 2027 (FY26 20-F + OFC 2027): full-year 2026 revenue + risk-factor disclosure + industry-architecture-trend visibility. The single-largest data-density window in the calendar.
- 2027-2028 hyperscaler customer naming (if any): the catalyst that distinguishes POET from a permanent option-on-pluggables business model. Hyperscaler-tier customer disclosure is the qualitative event that supports a structural re-rating.
If all three windows confirm the bull thesis, bull case Pillar 5’s $1.5B-$3B EV scenarios become reachable. If any one window confirms the bear thesis (production miss, going-concern flag, no hyperscaler engagement), bear case Pillar 1’s continued-dilution math dominates and the equity drifts toward the cash-floor support level.